Real Drugs Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 20 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.50 Cr
as on 17-11-2024
- Revenue -67.35%
(FY 2023)
- Profit 6.14%
(FY 2023)
- Ebitda -295.92%
(FY 2023)
- Net Worth -546.52%
(FY 2023)
- Total Assets 222.21%
(FY 2023)
About Real Drugs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.50 Cr.
Naresh Goyal, Kapil Goyal, and Manoj Jha serve as directors at the Company.
- CIN/LLPIN
U24239DL2004PTC129775
- Company No.
129775
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Oct 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Real Drugs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naresh Goyal  | Additional Director | 24-May-2024 | Current |
| Kapil Goyal | Director | 23-Jun-2021 | Current |
| Manoj Jha | Additional Director | 23-Sep-2024 | Current |
Financial Performance of Real Drugs.
Real Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 67.35% decrease. The company also saw a slight improvement in profitability, with a 6.14% increase in profit. The company's net worth observed a substantial decline by a decrease of 546.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Real Drugs?
In 2023, Real Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Intact Drugs And Pharmaceuticlas Pvt.Ltd.Active 32 years 9 months
Naresh Goyal and Kapil Goyal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 19 Jun 2024 | ₹2.50 Cr | Open |
How Many Employees Work at Real Drugs?
Unlock and access historical data on people associated with Real Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Real Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Real Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
